Answers are grounded in this paper and cite their sources.
The case presented here illustrates how convincingly the recovery from agranulocytosis may mimic acute leukemia in both the peripheral blood and the bone marrow. The development of a leukemia-like syndrome in any patient who has been exposed to a drug known to cause agranulocytosis should raise the question of "pseudoleukemia." Repeated bone marrow aspirations and daily observation of changes in peripheral blood parameters will help prevent needless exposure to myelosuppressive agents. The experience with this case makes mandatory an awareness of agranulocytosis as a side effect of dapsone.
No takes yet. Share an insight, caveat, or question.
Peter H. Levine (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: